Cell-cycle inhibitor profiling by high-content analysis

Fabio Gasparri1, Antonella Ciavolella, Arturo Galvani

  • 1Department of Biology, Nerviano Medical Sciences, Milano, Italy. fabio.gasparri@nervianoms.com

Insights

This study introduces a High-Content Analysis (HCA) method to screen for novel cancer cell division inhibitors. The approach uses multiparametric cellular analysis to confirm the mechanism of action for potential oncology drugs.

Area of Science:

  • Oncology
  • Cell Biology
  • Drug Discovery

Background:

  • Targeting cell-cycle machinery is crucial for oncology drug discovery.
  • Multiparametric cellular analysis aids in confirming the mechanism of action (MOA) of compounds.
  • High-Content Analysis (HCA) uses automated microscopy for detailed cellular response assessment.

Purpose of the Study:

  • To present a multiparametric HCA approach for characterizing potential cell-cycle inhibitors.
  • To evaluate compound-induced cell-cycle perturbations in osteosarcoma U-2 OS cells.
  • To establish a cellular and molecular phenotype fingerprint for each compound.

Main Methods:

  • Utilized automated microscopy and multiparametric analysis of fluorescent indicators.
  • Monitored specific cellular markers: nuclear morphology, DNA content, and histone H3 phosphorylation.
  • Assessed DNA damage response and apoptosis induction across various compound concentrations.

Main Results:

  • Developed a HCA approach to characterize cell-cycle inhibitors in osteosarcoma cells.
  • Enabled monitoring of compound-induced cell-cycle perturbations and associated cellular responses.
  • Generated compound-specific fingerprints based on cellular marker profiles.

Conclusions:

  • Multiparametric HCA is effective for characterizing potential cell-cycle inhibitors.
  • This method facilitates the confirmation of MOA for oncology drug candidates.
  • The fingerprinting approach aids in understanding compound-induced cellular phenotypes.